TY - JOUR AU - Kourlaba, Georgia AU - Relakis, John AU - Mahon, Ronan AU - Kalogeropoulou, Maria AU - Pantelopoulou, Georgia AU - Kousidou, Olga AU - Maniadakis, Nikos PY - 2016 DA - 2016/04/14 TI - Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema JO - Cost Effectiveness and Resource Allocation SP - 7 VL - 14 IS - 1 AB - To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting. SN - 1478-7547 UR - https://doi.org/10.1186/s12962-016-0056-1 DO - 10.1186/s12962-016-0056-1 ID - Kourlaba2016 ER -